Gene · 23495
Papers2,649
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,649
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sustained clinical stability with telitacicept-containing maintenance therapy following glucocorticoid and IVIG induction for lupus enteritis with autoimmune hemolytic anemia: a case report. | Front Immunol | 2026 | 42780083 | PubTator, text mining | PubMed |
| BAFF and APRIL Receptors in B Cell Immunity and Autoimmunity. | Immunol Rev | 2026 | 42755123 | PubTator, text mining | PubMed |
Prevalence, associated clinical factors, and genetic characteristics of endocrinopathies in common variable immunodeficiency: a retrospective study of 95 adult patients from a single tertiary care center. | Front Immunol | 2026 | 42707139 | PubTator, text mining | PubMed |
| Toward Precision Oral Medicine in Pemphigus Vulgaris: A Conceptual AI Framework for Rituximab Response Prediction. | Pharmaceuticals (Basel) | 2026 | 42653788 | PubTator, text mining | PubMed |
| Clinical Heterogeneity of TNFRSF13B Variants: A Monogenic Cause or a Genetic Modifier? | Immunology | 2026 | 42601324 | PubTator, text mining | PubMed |
| BAFF and APRIL signaling in the B-cell lineage: implications for the pathogenesis of ANCA-associated vasculitis. | Front Immunol | 2026 | 42553115 | PubTator, text mining | PubMed |
| The Myeloma Risk Variant of TNFRSF13B Shows Reduced NF-κB Signalling Activity in HEK293 Cells. | Eur J Haematol | 2026 | 42548249 | PubTator, text mining | PubMed |
| Vaccine Responses in Early Age. | Vaccines (Basel) | 2026 | 42506666 | PubTator, text mining | PubMed |
| Balancing Act: The Dual Roles of BAFF in Systemic Lupus Erythematosus. | Drugs | 2026 | 42479350 | PubTator, text mining | PubMed |
| Telitacicept treatment for active antibody-mediated rejection after kidney transplantation: a case series. | J Nephrol | 2026 | 42475488 | PubTator, text mining | PubMed |
| Potential role of Akkermansia massiliensis in multiple sclerosis protection by the FcRL3 gene. | Genes Immun | 2026 | 42436285 | PubTator, text mining | PubMed |
| Inhibition of mitochondrial ROS by TACI sustains bone marrow plasma cells. | Nat Commun | 2026 | 42436126 | PubTator, text mining | PubMed |
| Rheumatoid factor production is genetically and molecularly distinct from rheumatoid arthritis. | J Clin Invest | 2026 | 42378266 | PubTator, text mining | PubMed |
| TNFRSF13B Common Variants Enhance Antibody-Dependent Complement Activation and Susceptibility to Acute Respiratory Distress Syndrome Following Respiratory Viral Infection. | medRxiv | 2026 | 42282164 | PubTator, text mining | PubMed |
| Dual BAFF/APRIL inhibition with telitacicept in systemic lupus erythematosus and IgA nephropathy: pharmacological rationale, clinical efficacy, and safety on female fertility preservation. | Front Pharmacol | 2026 | 42244869 | PubTator, text mining | PubMed |
| Engineering a TACI × CD3 bispecific antibody to redirect T cells against multiple myeloma. | Blood Adv | 2026 | 42234959 | PubTator, text mining | PubMed |
| Zigakibart Potently Inhibits A Proliferation-Inducing Ligand-Mediated IgA Production, Addressing IgAN Pathogenesis Root Causes. | Kidney Int Rep | 2026 | 42205925 | PubTator, text mining | PubMed |
| A Functional TNFRSF13B Variant Disrupts B-Cell Enhancer Activity and Increases Susceptibility to EBV-Negative Lymphoma. | Gene | 2026 | 42114689 | PubTator, text mining | PubMed |
| The Coexistence of Asthma and Common Variable Immunodeficiency in a Patient with TNFRSF13B Gene Mutation. | Iran J Allergy Asthma Immunol | 2026 | 42113500 | PubTator, text mining | PubMed |
| Suppressor of cytokine signaling 1 haploinsufficiency in a patient with granulomatous lymphocytic interstitial lung disease and inflammatory bowel disease-like disease. | Clin Exp Immunol | 2026 | 42102262 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23495/papers